conduct
retrospect
studi
children
receiv
medic
care
ill
necessit
collect
nasopharyng
specimen
respiratori
pathogen
test
colorado
august
epidemiolog
week
confirm
afm
case
identifi
afm
casepati
defin
children
year
age
acut
neurolog
ill
character
focal
weak
limb
magnet
reson
imag
mri
find
spinal
cord
lesion
larg
restrict
gray
matter
identifi
etiolog
per
cdc
case
definit
also
identifi
control
group
children
nasopharyng
specimen
obtain
chco
outpati
studi
period
select
outpati
control
afm
casepati
respiratori
sign
symptom
evalu
outpati
neurolog
symptom
develop
first
control
group
respiratori
pathogen
panel
rpp
control
includ
children
evalu
outpati
nasopharyng
specimen
test
multiplex
rpp
pcr
filmarray
biofir
diagnost
llc
salt
lake
citi
ut
usa
detect
adenoviru
coronavirus
influenza
virus
b
metapneumoviru
parainfluenza
virus
respiratori
syncyti
virus
b
enterovirusrhinoviru
bordetella
pertussi
chlamydophila
pneumonia
mycoplasma
pneumonia
second
control
group
b
pertussi
bp
control
includ
children
evalu
outpati
nasopharyng
specimen
obtain
pcr
test
b
pertussi
exclud
studi
infant
month
age
children
year
age
afm
patient
age
group
identifi
colorado
period
multipl
specimen
child
submit
test
differ
time
studi
first
includ
specimen
submit
rpp
bp
test
child
date
consid
rpp
analysi
also
analyz
result
filmarray
test
patient
admit
pediatr
intens
care
unit
picu
chco
chose
popul
patient
admit
respiratori
symptom
routin
undergo
filmarray
test
result
would
provid
repres
view
pathogen
circul
commun
result
sever
respiratori
ill
time
outbreak
nasopharyng
specimen
afm
patient
initi
test
use
filmarray
panel
sensit
specif
detect
enterovirus
rhinovirus
unabl
distinguish
specimen
posit
enterovirusrhinoviru
sent
cdc
enteroviru
viral
protein
vp
seminest
revers
transcript
pcr
rtpcr
follow
molecular
sequenc
amplicon
octob
new
highli
sensit
realtim
rtpcr
rrtpcr
assay
develop
cdc
sampl
afm
patient
also
test
use
assay
filmarray
test
first
conduct
rpptest
control
specimen
posit
enterovirusrhinoviru
subsequ
sent
cdc
along
bptest
specimen
cdc
rpp
bptest
control
specimen
test
use
rrtpcr
assay
panenterovirus
perform
similarli
seminest
pcr
assay
specimen
also
test
rrtpcr
specimen
posit
panenteroviru
rtrpcr
also
molecularli
sequenc
viru
identif
sampl
picu
patient
test
first
filmarray
panel
chco
posit
sampl
sent
cdc
underw
seri
test
control
main
exposur
interest
infect
defin
posit
result
obtain
rrtpcr
nasopharyng
specimen
second
exposur
interest
infect
anoth
enterovirusrhinoviru
defin
posit
result
panenteroviru
rrtpcr
neg
result
rrtpcr
infect
enterovirusesrhinovirus
group
refer
enterovirusesrhinovirus
exclud
chosen
provid
comparison
group
covari
includ
continu
variabl
age
sex
day
symptom
onset
collect
nasopharyng
specimen
epidemiolog
week
nasopharyng
specimen
collect
categor
variabl
fever
yesno
upper
andor
lower
respiratori
symptom
includ
nasal
congest
rhinorrhea
sore
throat
cough
wheez
respiratori
distress
yesno
hospit
respiratori
symptom
yesno
type
nasopharyng
specimen
obtain
swabaspir
although
enteroviru
detect
nasopharyng
aspir
nasopharyng
swab
sampl
similar
pathogen
might
identifi
nasopharyng
swab
sampl
ensur
differ
exist
group
regard
variabl
includ
model
descript
analys
report
characterist
afm
casepati
control
children
median
interquartil
rang
provid
age
day
symptom
onset
collect
nasopharyng
specimen
variabl
normal
distribut
proport
report
categor
variabl
nonparametr
wilcoxonmannwhitney
test
use
detect
signific
differ
continu
variabl
proport
categor
variabl
variabl
differ
significantli
afm
casepati
control
p
includ
adjust
multivari
model
except
epidemiolog
week
sampl
collect
includ
adjust
model
regardless
statist
signific
model
assess
afm
casepati
versu
rpptest
control
adjust
age
time
respiratori
symptom
onset
specimen
collect
epidemiolog
week
specimen
collect
model
assess
afm
casepati
versu
bptest
control
adjust
type
nasopharyng
specimen
presenc
fever
epidemiolog
week
sampl
collect
report
odd
ratio
ci
p
valu
logist
regress
analys
model
perform
use
exact
condit
analysi
small
sampl
size
multivari
model
p
consid
statist
signific
test
model
comparison
afm
control
group
model
test
associ
afm
model
test
associ
enterovirusrhinoviru
exclud
afm
determin
sensit
model
among
case
neurolog
weak
includ
acut
cranial
nerv
deficit
without
limb
weak
also
conduct
sensit
analysi
among
patient
colorado
acut
neurolog
weak
nasopharyng
specimen
avail
model
covari
use
analysi
use
main
analysi
analys
perform
sa
statist
softwar
packag
version
sa
institut
inc
cari
nc
usa
conduct
sensit
analysi
includ
children
met
origin
colorado
case
definit
definit
includ
patient
cranial
nerv
dysfunct
meet
cdc
afm
case
definit
criteria
lack
acut
limb
weak
compat
spinal
mri
find
nasopharyng
specimen
collect
patient
posit
yield
case
subanalysi
result
differ
appreci
main
analysi
tabl
studi
demonstr
epidemiolog
associ
infect
afm
among
children
colorado
outbreak
odd
infect
time
higher
children
afm
rpptest
control
time
higher
bptest
control
odd
fever
also
higher
afm
casepati
bptest
control
find
surpris
given
clinic
pictur
associ
pertussi
elev
odd
infect
afm
casepati
compar
rpptest
control
suggest
preval
infect
among
afm
casepati
like
reflect
background
circul
viru
outbreak
moreov
outbreak
associ
seem
uniqu
infect
enterovirus
rhinovirus
common
respiratori
pathogen
identifi
filmarray
significantli
associ
afm
age
confound
analysi
rpptest
control
younger
reflect
median
year
age
report
respiratori
outbreak
older
age
afm
casepati
similar
median
year
report
us
descript
afm
case
howev
data
europ
wale
describ
similar
diseas
younger
children
report
case
neurolog
dysfunct
laboratori
evid
infect
europ
patient
year
age
addit
wale
age
cluster
children
acut
flaccid
paralysi
respiratori
symptom
preced
acut
flaccid
paralysi
posit
predominantli
year
slightli
discrep
data
may
indic
small
sampl
size
afm
case
highlight
need
continu
surveil
better
defin
epidemiolog
afm
case
preval
nasopharyng
specimen
control
studi
lower
expect
given
common
presenc
picu
patient
although
rate
commun
us
outbreak
unknown
data
respiratori
ill
outbreak
asia
europ
suggest
similar
low
preval
rate
posit
nasopharyng
specimen
among
hospit
children
respiratori
symptom
among
outpati
respiratori
symptom
preval
among
control
much
lower
seen
among
picu
patient
suggest
either
disproportion
high
acuiti
respiratori
diseas
test
select
test
clinician
outpati
set
compar
intens
care
set
outbreak
progress
offici
chco
respiratori
ill
algorithm
discourag
clinician
test
children
respiratori
symptom
seen
emerg
outpati
set
clinic
manag
would
chang
treat
outpati
children
routin
respiratori
symptom
seen
emerg
room
urgent
care
outpati
clinic
sampl
children
infect
would
miss
tri
account
potenti
declin
outpati
test
way
first
although
find
week
specimen
collect
statist
confound
nonetheless
includ
multivari
model
second
chose
addit
control
group
children
test
b
pertussi
clinic
syndrom
pertussi
children
probabl
differ
respiratori
symptom
among
children
acut
respiratori
ill
bptest
children
probabl
sampl
systemat
rule
b
pertussi
infect
specimen
thu
less
like
test
bia
rpptest
control
group
bptest
control
saw
posit
associ
afm
casepati
presenc
similar
clinic
present
picornavirus
lend
biolog
plausibl
associ
afm
enterovirus
enteroviru
polioviru
caus
neurolog
syndrom
includ
acut
flaccid
paralysi
asept
mening
rhomboenceph
mri
find
cluster
children
studi
similar
induc
polioviru
show
tropism
anterior
horn
cell
spinal
cord
although
infrequ
infect
central
nervou
system
similar
initi
link
nonneurolog
syndrom
specif
herpangina
hand
foot
mouth
diseas
outbreak
data
conclus
reveal
associ
neurolog
syndrom
studi
cluster
afm
case
detect
upper
respiratori
tract
patient
blood
howev
expect
found
site
person
respiratori
ill
detect
specimen
prove
causat
afm
identif
cerebrospin
fluid
provid
definit
evid
causat
report
cluster
nonetheless
studi
compar
detect
afm
casepati
detect
contemporan
control
patient
mild
respiratori
ill
lend
addit
epidemiolog
support
ecolog
associ
afm
analysi
subject
sever
limit
first
although
ideal
control
group
would
includ
populationbas
sampl
ageappropri
children
denver
metropolitan
area
afm
outbreak
group
logist
possibl
therefor
use
retrospect
outpati
control
rtpcr
diagnost
test
perform
discret
provid
chco
specimen
retain
avail
test
control
probabl
reflect
children
commun
sampl
might
bias
repres
children
mild
respiratori
symptom
requir
hospit
higher
preval
among
picu
patient
suggest
preval
commun
higher
sampl
children
mild
respiratori
symptom
upper
respiratori
specimen
collect
howev
given
afm
casepati
children
mild
respiratori
prodrom
control
group
repres
degre
respiratori
ill
seen
casepati
picu
patient
second
respiratori
specimen
obtain
much
shorter
interv
patient
rppcontrol
group
patient
afm
casepati
bpcontrol
group
delay
might
led
lower
preval
pathogen
latter
group
would
found
test
perform
sooner
third
nasopharyng
specimen
steril
presenc
virus
sampl
might
coincident
caus
afm
associ
presenc
nasopharynx
afm
might
also
bias
unmeasur
unrecogn
confound
fourth
rppneg
specimen
chco
sent
cdc
enterovirusrhinoviru
rrtpcr
test
although
sensit
filmarray
assay
test
may
miss
case
fifth
also
note
posit
measur
associ
enterovirusrhinoviru
exposur
afm
among
control
group
although
neither
associ
statist
signific
howev
analysi
adequ
sampl
size
enabl
explor
associ
last
although
model
includ
variabl
time
specimen
collect
limit
sampl
size
afm
casepati
unabl
complet
control
variabl
analys
close
match
time
specimen
collect
shown
conclus
found
epidemiolog
associ
afm
infect
among
children
respiratori
ill
colorado
find
goe
beyond
previous
report
tempor
associ
afm
cluster
increas
hospit
admiss
respiratori
symptom
detect
afm
casepati
epidemiolog
data
combin
biolog
plausibl
associ
suggest
possibl
causal
link
howev
gap
remain
epidemiolog
data
data
extens
test
laboratori
specimen
cdc
recommend
continu
surveil
revis
case
definit
without
age
restrict
implement
investig
associ
improv
surveil
afm
time
comprehens
specimen
collect
test
need
